Poseida Therapeutics, Inc.
PSTXDelisted Jan 8, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001661460
Poseida Therapeutics, Inc. was delisted on Jan 8, 2025; its insiders filed their last Form 4 on Jan 10, 2025; 116 institutions reported holding it in 13F filings for Q4 2024, worth $519.2M in total; no superinvestor held it.
13F holders, Q3 2024
Institutional positions in Poseida Therapeutics, Inc. as of Sep 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 96
- +4 vs. Q2 2024
- Shares held
- 53.6M
- +5.46M (+11.3%) vs. Q2 2024
- Total value
- $153.4M
- +$12.8M (+9.1%) vs. Q2 2024
- New holders
- 17
- 35 more added
- Sold out
- 13
- 21 more reduced
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PSTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 0 | $0 |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 2 | $308.0K |
| Q4 2024 | 116 | $519.2M |
| Q3 2024 | 96 | $153.4M |
| Q2 2024 | 93 | $154.9M |
| Q1 2024 | 91 | $168.6M |
| Q4 2023 | 91 | $152.4M |
| Q3 2023 | 86 | $107.6M |
| Q2 2023 | 94 | $78.4M |
| Q1 2023 | 102 | $136.0M |
| Q4 2022 | 89 | $227.6M |
| Q3 2022 | 68 | $141.8M |
| Q2 2022 | 56 | $58.1M |
| Q1 2022 | 64 | $108.4M |
| Q4 2021 | 66 | $178.4M |
| Q3 2021 | 65 | $190.7M |
| Q2 2021 | 71 | $279.3M |
| Q1 2021 | 62 | $276.3M |
Institutions, Q3 2024
Shares, value and share of portfolio for each institution holding Poseida Therapeutics, Inc.; share changes are against Q2 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −16,006−100.0% | Sold out |
| Principal Financial Group Inc | 0 | $0 | 0.00% | −12,006−100.0% | Sold out |
| Graham Capital Management, L.P. | 0 | $0 | 0.00% | −11,004−100.0% | Sold out |
| Verition Fund Management LLC | 0 | $0 | 0.00% | −10,673−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −9,216−100.0% | Sold out |
| Central Bank & Trust Co | 0 | $0 | 0.00% | −7,608−100.0% | Sold out |
| US Bancorp | 0 | $0 | 0.00% | −5,200−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −1,335−100.0% | Sold out |
| nVerses Capital, LLC | 0 | $0 | 0.00% | −800−100.0% | Sold out |
| BlackRock Inc. | – | – | – | – | Not filed |